Bio-Rad Laboratories, Inc. has grown revenue −2.2% a year over three years and −2.1% a year over five. Revenue growth, 3-year annual rate: −2.2% (Medical Devices median +12%). Revenue growth, 5-year rate: −2.1%, growth has slowed since the five-year average. Years of annual history on file: 18, FY2008 to FY2025, as filed.

BIOBio-Rad Laboratories, Inc.

Healthcare

$366.40+29% 1Y

$366.40

$241.7152 weeks$390.31

Is it growing?

Watch

Growth is fading: earnings down −32% year on year and operating margin narrowing (−6.2 points).

2 to watch, 1 neutral

Revenue trend+1% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −2% a year.

Earnings trend−32% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−6.2 points operating

Trailing-twelve-month operating margin, 2.4% now against 8.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 88% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BIO growing?

Bio-Rad Laboratories, Inc. has grown revenue −2.2% a year over three years and −2.1% a year over five.

−2.2%

Revenue growth, 3-year annual rate · Medical Devices median +12% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −2.1%
Revenue growth, 5-year rate · −2.2% over three · growth has slowed since the five-year average
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed

Details›